Evidence map›Paper›PMID 24934569›Full record

ArticleHuman mutation2014

Identification of novel craniofacial regulatory domains located far upstream of SOX9 and disrupted in Pierre Robin sequence.

Christopher T Gordon, Catia Attanasio, Shipra Bhatia, Sabina Benko, Morad Ansari, Tiong Y Tan, Arnold Munnich, Len A Pennacchio, Véronique Abadie, I Karen Temple and 7 more

Open access · greenAbstract read
In one paragraph

Article in Human mutation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Evidence-based classification of genes implicated in skeletal disorders using the ClinGen curation framework.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. SOX9 in organogenesis: shared and unique transcriptional functions.Cellular and molecular life sciences : CMLS · 2022
    Review
  15. Article
  16. Review
  17. Interpreting the impact of noncoding structural variation in neurodevelopmental disorders.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Review
  18. Review
  19. Super-Enhancers and CTCF in Early Embryonic Cell Fate Decisions.Frontiers in cell and developmental biology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 5 countries.

Christopher T GordonUniversité Paris Descartes-Sorbonne Paris Cité, Institut Imagine, INSERM U1163, Paris, France.
Catia Attanasio
Shipra Bhatia
Sabina Benko
Morad Ansari
Tiong Y Tan
Arnold Munnich
Len A Pennacchio
Véronique Abadie
I Karen Temple
Alice Goldenberg
Veronica van Heyningen
Jeanne Amiel
David FitzPatrick
Dirk A Kleinjan
Axel Visel
Stanislas Lyonnet
MRC Institute of Genetics and Molecular Medicine · GBUniversité Paris Cité · FRLawrence Berkeley National Laboratory · USSorbonne Paris Cité · FRDélégation Paris 5 · FRHôpital Charles-Nicolle · FRJoint Genome Institute · USUniversity of Edinburgh · GBUniversity of Southampton · GBVictorian Clinical Genetics Services · AU

Funding

Generation of an In Vivo Human Genome Transcriptional Enhancer DatasetR01HG003988 · NHGRI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Len Alexander Pennacchio · 2006 to 2026
$24.1M
Genomic, Transgenic and Knockout Resources for Craniofacial Enhancer StudiesU01DE024427 · NIDCR · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI VISEL, AXEL · 2014 to 2018
$3.7M
Research Project: Genome-Wide Atlas of Craniofacial Transcriptional EnhancersU01DE020060 · NIDCR · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI VISEL, AXEL · 2009 to 2013
$2.1M
Medical Research Council MC_PC_U127527199Medical Research Council MC_PC_U127561093Medical Research Council MC_U127527199NHGRI NIH HHS R01 HG003988NHGRI NIH HHS R01HG003988NIDCR NIH HHS U01 DE020060NIDCR NIH HHS U01DE020060NIDCR NIH HHS U01 DE024427
6 · The paper itself

Abstract

Mutations in the coding sequence of SOX9 cause campomelic dysplasia (CD), a disorder of skeletal development associated with 46,XY disorders of sex development (DSDs). Translocations, deletions, and duplications within a ∼2 Mb region upstream of SOX9 can recapitulate the CD-DSD phenotype fully or partially, suggesting the existence of an unusually large cis-regulatory control region. Pierre Robin sequence (PRS) is a craniofacial disorder that is frequently an endophenotype of CD and a locus for isolated PRS at ∼1.2-1.5 Mb upstream of SOX9 has been previously reported. The craniofacial regulatory potential within this locus, and within the greater genomic domain surrounding SOX9, remains poorly defined. We report two novel deletions upstream of SOX9 in families with PRS, allowing refinement of the regions harboring candidate craniofacial regulatory elements. In parallel, ChIP-Seq for p300 binding sites in mouse craniofacial tissue led to the identification of several novel craniofacial enhancers at the SOX9 locus, which were validated in transgenic reporter mice and zebrafish. Notably, some of the functionally validated elements fall within the PRS deletions. These studies suggest that multiple noncoding elements contribute to the craniofacial regulation of SOX9 expression, and that their disruption results in PRS.

Indexed as

Enhancer Elements, GeneticAdultAnimalsBase SequenceCampomelic DysplasiaChildChromosomes, Human, Pair 17FemaleGenetic LociHumansMaleMandibleMiceMice, TransgenicMolecular Sequence DataMutationp300-CBP-Associated Factorp300-CBP Transcription FactorsSOX9 protein, humanSox9 protein, mouseSOX9 Transcription Factorcampomelic dysplasiacraniofacialenhancerlong-range regulationPierre RobinSOX9

Identifiers

PMID24934569
PMCPMC4389788
OpenAlexW2057172887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.